Chemical Name: 1-Cyclohexyl-2-(5H-imidazo[5,1-a]isoindol-5-yl)ethanol
IDO pathway inhibitor
Molekulargewicht:
282.39
Reinheit:
985 by TLC, NMR (Conforms)
Formulierung:
White solid
CAS Nummer:
[1402836-58-1]
Formel:
C18H22N2O
Anwendungsbeschreibung:
NLG919 (1402836-58-1) is a potent IDO-pathway inhibitor (Ki = 7nM, EC50 = 75nM).1 It synergizes with chemo-radiation therapy to promote T cell dependent complement deposition in a murine model of glioblastoma.2 In combination with paclitaxel in a mouse B16-F10 melanoma model, NLG919 increased the percentage of CD3+, CD8+, and CD4+ T cells and secretion of IFN-gamma and interleukin-2 while decreasing the percentage of CD4+CD25+ regulatory T cells.3
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten